New York, NY, United States of America

Chuanjuan Tao

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 8.7

ph-index = 4

Forward Citations = 67(Granted Patents)


Location History:

  • New York, NY (US) (2019 - 2023)
  • Fort Lee, NJ (US) (2021 - 2024)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Chuanjuan Tao: Innovator in Nucleic Acid Sequencing

Introduction

Chuanjuan Tao is a prominent inventor based in New York, NY, known for his significant contributions to the field of nucleic acid sequencing. With a total of 15 patents to his name, he has made remarkable advancements in the development of nucleotide derivatives and their applications.

Latest Patents

Among his latest patents, one notable invention is focused on nucleotide derivatives and methods of use thereof. This patent discloses compounds, compositions, and methods that facilitate the sequencing of nucleic acids. Another important patent involves nucleotide analogues and their use for nucleic acid sequencing and analysis. This invention provides various orthogonal nucleotide analogues and methods for utilizing combinations of these analogues for sequencing by synthesis.

Career Highlights

Chuanjuan Tao has had a distinguished career, working with esteemed institutions such as Columbia University and the Government of the United States of America, as represented by the Secretary of Commerce. His work has significantly impacted the scientific community and has paved the way for advancements in genetic research.

Collaborations

Throughout his career, Chuanjuan has collaborated with notable colleagues, including Jingyue Ju and Shiv R Kumar. These collaborations have further enhanced his research and innovation in the field.

Conclusion

Chuanjuan Tao's contributions to nucleic acid sequencing and his extensive patent portfolio highlight his role as a leading inventor in the field. His work continues to influence advancements in genetic research and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…